30 reports

  • Nov 21, 2017: Cure Brain Cancer Foundation: 2017 Grant Recipients Announced

Nov ##, 2017: Research uncovers potential new approach for treating asthma There may be fresh hope for asthma sufferers who experience an attack brought on by the common cold.

  • Brain Cancer
  • Healthcare
  • Pharmaceutical
  • Therapy
  • Australia

NO has a solid place in asthma management.

  • Drug Test
  • United States
  • Alere Inc.
  • Dräger Group
  • Thermo Fisher Scientific, Inc.

Each unit consists of one share of common stock, one-half of one series A common stock purchase warrant, one series B common stock purchase warrant and one series C common stock purchase warrant.

  • Brain Cancer
  • Therapy
  • United States
  • Corporate Finance
  • Inspyr Therapeutics, Inc.
  • Novogen Enters into Licensing Agreement with Genentech for GDC-0084

The company' s product pipeline includes PI##K GDC-##; Cantrixil (TRX-E-##-##); Trilexium (TRXE-##-##).

  • Brain Cancer
  • Australia
  • United States
  • M&A
  • Novogen Limited
  • PIPELINE BY AUTOTELIC INC, H1 2017
  • PIPELINE BY GENZYME CORP, H1 2017

Its product pipeline comprises Dupilumab for atopic dermatitis and asthma; Patisiran for familial amyloid polyneuropathy; Isatuximab for multiple myeloma; and Fitisuran for Hemophilia, among others.

  • Brain Cancer
  • Ophthalmology
  • Therapy
  • Product Initiative
  • Isarna Therapeutics GmbH
  • Novogen Enters into Licensing Agreement with Genentech for GDC-0084

The company' s product pipeline includes PI##K GDC-##; Cantrixil (TRX-E-##-##); Trilexium (TRXE-##-##).

  • Brain Cancer
  • Australia
  • United States
  • M&A
  • Novogen Limited

One of five awards totaling $## million, the award to Dr.

  • Brain Cancer
  • Cancer
  • Genomics
  • United States
  • GlobalData's company

Similarly, the universities portfolio in Preclinical and Discovery stages comprises ## and ## molecules, respectively.

  • Brain Cancer
  • Targeted Therapy
  • World
  • Product Initiative
  • IMMD

Concurrently novel inhibitors of IL-## and IL-## for the treatment of asthma and atopic dermatitis are being explored.

  • Brain Cancer
  • Digestive System Disorder
  • Drug Test
  • Hospital
  • MediciNova, Inc.
  • Mechanism Of Action

Similarly, the universities portfolio in Preclinical and Discovery stages comprises ## and ## molecules, respectively.

  • Brain Cancer
  • Therapy
  • World
  • Product Initiative
  • IMMD
  • PIPELINE BY GENZYME CORP, H2 2017

Its product pipeline comprises Dupilumab for atopic dermatitis and asthma; Patisiran for familial amyloid polyneuropathy; Isatuximab for multiple myeloma; and Fitisuran for Hemophilia, among others.

  • Brain Cancer
  • Ophthalmology
  • Therapy
  • World
  • Isarna Therapeutics GmbH

Hoffmann-La Roche Ltd Partner ## Partner ## Deal status Completed DEAL IN BRIEF Deal sub-category Date of announcement Date of completion DEAL RATIONALE Licensing agreement Dec ##, 2017 Dec ##, 2017 COMPANY INFORMATION: PARTNERS PARTNER ##: F.

  • Brain Cancer
  • Cancer
  • Pharmaceutical
  • Therapy
  • Ionis Pharmaceuticals, Inc.

Partner ## Partner ## Deal status Deal category Deal sub-category Date of completion COMPANY INFORMATION: PARTNERS Company type PARTNER ##: NEOFLUIDICS.

  • Brain Cancer
  • Healthcare
  • Pharmaceutical
  • Therapy
  • Pfizer Inc.

Hoffmann-La Roche Ltd Partner ## Partner ## Deal status Completed DEAL IN BRIEF Deal sub-category Date of announcement Date of completion DEAL RATIONALE Licensing agreement Dec ##, 2017 Dec ##, 2017 COMPANY INFORMATION: PARTNERS PARTNER ##: F.

  • Brain Cancer
  • Cancer
  • Pharmaceutical
  • Therapy
  • Ionis Pharmaceuticals, Inc.

Company information: Partners Company type Partner ##: U. S.

  • Brain Cancer
  • Healthcare
  • Pharmaceutical
  • Therapy
  • Novartis AG

Partner ## Partner ## Deal status Deal category Deal sub-category Date of completion COMPANY INFORMATION: PARTNERS Company type PARTNER ##: NEOFLUIDICS.

  • Brain Cancer
  • Healthcare
  • Pharmaceutical
  • Therapy
  • Pfizer Inc.

The exchange ratio reflects a ##-for-## reverse stock split effected by Threshold prior to the completion of the merger.

  • Brain Cancer
  • Cancer
  • Healthcare
  • Pharmaceutical
  • Threshold

Bio One Capital Pte Ltd.

  • Brain Cancer
  • Cancer
  • Pharmaceutical
  • Therapy
  • Forma Publishing Group

Company type Business description COMPANY INFORMATION: PARTNERS PARTNER ##: INNOVATIVE TARGETING SOLUTIONS, INC.

  • Brain Cancer
  • Healthcare
  • Immunology
  • Pharmaceutical
  • Zymeworks Inc.

It is also developing new approaches to the treatment of asthma.

  • Brain Cancer
  • Cancer
  • Hospital
  • Therapy
  • Bristol-Myers Squibb Company

Its product portfolio includes pharmaceuticals for the treatment of diseases such as type II diabetes, overactive bladder, osteoporosis, Alzheimer' s disease, peripheral circulatory disorder, bronchial asthma and allergic rhinitis, among others.

  • Brain Cancer
  • Cancer
  • Hospital
  • Therapy
  • Bristol-Myers Squibb Company

Its product portfolio includes pharmaceuticals for the treatment of diseases such as type II diabetes, overactive bladder, osteoporosis, Alzheimer' s disease, peripheral circulatory disorder, bronchial asthma and allergic rhinitis, among others.

  • Brain Cancer
  • Cancer
  • Hospital
  • Therapy
  • Bristol-Myers Squibb Company

Its target treatment areas comprise endobronchial cancer, esophageal cancer, high grade dysplasia in Barrett' s esophagus, asthma and head lice infestation among others.

  • Brain Cancer
  • Therapy
  • United States
  • Product Initiative
  • Bristol-Myers Squibb Company

The company has a pipeline of an anti-Programmed Cell Death Protein ## (PD-##) checkpoint inhibitor and other therapeutic cytokines.

  • Brain Cancer
  • Healthcare
  • Pharmaceutical
  • Corporate Finance
  • ARMO Biosciences, Inc.
  • PONTINE GLIOMA - PIPELINE BY ONO PHARMACEUTICAL CO LTD, H2 2017

Its product portfolio includes pharmaceuticals for the treatment of diseases such as type II diabetes, overactive bladder, osteoporosis, Alzheimer' s disease, peripheral circulatory disorder, bronchial asthma and allergic rhinitis, among others.

  • Brain Cancer
  • Cancer
  • United States
  • Product Initiative
  • Bristol-Myers Squibb Company

Its target treatment areas comprise endobronchial cancer, esophageal cancer, high grade dysplasia in Barrett' s esophagus, asthma and head lice infestation among others.

  • Brain Cancer
  • Lung Cancer
  • United States
  • Product Initiative
  • Bristol-Myers Squibb Company

(formerly Champions PARTNER ##: CHAMPIONS ONCOLOGY, INC.

  • Brain Cancer
  • Cancer
  • Healthcare
  • Pharmaceutical
  • Morphotek, Inc.
  • RECURRENT GLIOBLASTOMA MULTIFORME (GBM) - PIPELINE BY ONO PHARMACEUTICAL CO., LTD., H1 2016

Ono Pharmaceutical products find application in the treatment of diseases such as type II diabetes, overactive bladder, osteoporosis, Alzheimer' s disease, peripheral circulatory disorder, bronchial asthma and allergic rhinitis, among others.

  • Brain Cancer
  • Hospital
  • Targeted Therapy
  • Therapy
  • Merck & Co., Inc.
  • RISK FACTORS

Neurotoxicology, ##(##), ##-##.

  • Brain Cancer
  • European Union
  • Japan
  • United States
  • Product Initiative
  • RECURRENT GLIOBLASTOMA MULTIFORME (GBM) - PIPELINE BY ONO PHARMACEUTICAL CO., LTD., H2 2016

Ono Pharmaceutical products find application in the treatment of diseases such as type II diabetes, overactive bladder, osteoporosis, Alzheimer' s disease, peripheral circulatory disorder, bronchial asthma and allergic rhinitis, among others.

  • Brain Cancer
  • Cancer
  • United States
  • Product Initiative
  • Merck & Co., Inc.